Stay updated on Medicenna Therapeutics Press Releases

Sign up to get notified when there's something new on the Medicenna Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Medicenna Therapeutics Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    Medicenna Therapeutics has reported its first quarter fiscal 2026 financial results and operational highlights, and has strengthened its intellectual property portfolio with five new patents. Notably, previous announcements regarding upcoming presentations and clinical updates have been removed.
    Difference
    93%
    Check dated 2025-08-01T19:09:32.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The webpage now includes a report on Medicenna Therapeutics' fiscal year 2025 financial results and operational highlights, while a previous report on MDNA11's anti-cancer activity and study update has been removed.
    Difference
    92%
    Check dated 2025-06-27T00:27:34.000Z thumbnail image
  6. Check
    95 days ago
    Change Detected
    Summary
    The webpage has been updated to include new presentations and results from Medicenna at the 2025 AACR Annual Meeting, while previous reports on financial results and investor conferences have been removed.
    Difference
    100%
    Check dated 2025-04-30T13:51:45.000Z thumbnail image
  7. Check
    102 days ago
    Change Detected
    Summary
    Medicenna is scheduled to present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on April 22, 2025.
    Difference
    12%
    Check dated 2025-04-23T08:22:29.000Z thumbnail image
  8. Check
    124 days ago
    Change Detected
    Summary
    Medicenna is scheduled to present at the Jones Healthcare and Technology Innovation Conference on April 1, 2025.
    Difference
    14%
    Check dated 2025-04-01T18:20:13.000Z thumbnail image
  9. Check
    153 days ago
    Change Detected
    Summary
    The page now includes a report from Medicenna detailing the anti-cancer activity of MDNA11 and its association with the expansion of cancer-fighting immune cells, along with an update on the ABILITY-1 study presented at the AACR-Immuno-Oncology Conference.
    Difference
    43%
    Check dated 2025-03-03T22:15:34.000Z thumbnail image

Stay in the know with updates to Medicenna Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Medicenna Therapeutics Press Releases page.